Pharmaceutical industry seeks biotech acquisitions as patents expire
by@Reuters
Summary
The pharmaceutical industry is grappling with the impending expiration of patents on drugs that account for over $400 billion in annual revenue by 2033. To address this challenge, major pharmaceutical companies, as noted by Leah Bennett of Concurrent, are increasingly acquiring smaller biotech firms that are developing new drugs. This trend of mergers and acquisitions is seen as a potentially positive development for investors, as it may help replenish the industry's drug pipelines.
Analysis
Concurrent: Concurrent Investment Advisors is a hybrid registered investment advisor firm that operates a platform supporting independent financial advisors with services including compliance, operations, investment due diligence, and access to custodians. Leah Bennett serves as its Chief Investment Strategist, regularly providing market commentary and sector analysis to media outlets such as Reuters. In this news, Bennett highlights how major pharmaceutical companies are responding to upcoming patent expirations by acquiring smaller biotech firms developing new treatments. M&A Trend: Major pharmaceutical companies are actively acquiring smaller biotechnology firms to replenish drug pipelines facing patent expirations. Sector Impact: Such acquisitions in the pharma and biotech space are viewed as potentially positive developments for investors.
Categories
macropolitics
Related sources
- https://x.com/Reuters/status/2023434698525925771
- https://poweredbyconcurrent.com/blog/sectors-up-close-ai-could-improve-drugmaker-revenues-by-12-featuring-leah-bennett/
- https://x.com/Reuters/status/2107187818414112978
- https://app.getwarmer.com/advisors/leah-bennett
- https://www.concurrentcio.com/our-team
- https://www.advisorhub.com/resources/platform-partnership-concurrent/
- https://www.wealthmanagement.com/ria-news/concurrent-makes-first-ria-platform-acquisition-with-5-4b-spire
- https://poweredbyconcurrent.com/blog/leah-bennett-on-reuters-sectors-up-close-biotech-investments-during-covid-paying-off/
- https://www.concurrentcio.com/team/leah-bennett
- https://www.reuters.com/jp/video/watch/idRW758905102026RP1/